Scoping review protocol documenting cancer outcomes and inequalities for adults living with intellectual and/or developmental disabilities.
cancer
cancer outcomes
health disparities
health equity
intellectual and developmental disabilities
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
03 11 2019
03 11 2019
Historique:
entrez:
6
11
2019
pubmed:
7
11
2019
medline:
3
11
2020
Statut:
epublish
Résumé
There is increasing attention on the cancer burden for adults with intellectual and developmental disabilities (IDD). Emerging evidence suggests there are differences in cancer experiences and outcomes for individuals living with IDD, from risk through survivorship. These differences may be attributed to features of the IDD, such as cognitive deficits and communication, as well as social determinants of health-like lower education levels and ableism. However, there is no comprehensive overview of the literature quantifying these potential disparities and describing the influencing factors. In this paper, we describe a scoping review protocol to systematically review published literature on cancer for adults with IDD. The purpose of this review is to identify differences in cancer risk, stage at diagnosis, treatment and survival along the cancer continuum for adults with IDD and outline potential contributing factors creating these disparities. We will follow Arksey and O'Malley's expanded framework for scoping reviews to conduct this review. We will systematically search electronic databases for peer-reviewed, published journal articles to identify appropriate studies in collaboration with a health science librarian. Two reviewers will independently review titles and abstracts followed by a full-text review to determine whether it meets inclusion criteria. A data chart for collecting and sorting information will be developed in consultation with the team. Results will be collated and reported following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension for scoping reviews: PRISMA-Scoping Reviews. Extracted information will be summarised quantitatively and qualitatively to meet review objectives. This scoping review will employ a methodology to identify literature related to cancer outcomes and experiences for adults with IDD. Results will be disseminated to relevant stakeholders who care for and support individuals with IDD at local, provincial and national levels and through publishing findings. By highlighting the disparities in the cancer system and gaps in the research, this scoping review can provide direction for future action.
Identifiants
pubmed: 31685515
pii: bmjopen-2019-032772
doi: 10.1136/bmjopen-2019-032772
pmc: PMC6858132
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e032772Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Can Fam Physician. 2018 Apr;64(4):254-279
pubmed: 29650602
Br J Cancer. 2009 Dec 3;101 Suppl 2:S92-S101
pubmed: 19956172
J Gen Intern Med. 2017 Jan;32(1):71-80
pubmed: 27848189
CA Cancer J Clin. 2015 Sep-Oct;65(5):384-400
pubmed: 26186412
Eur J Cancer. 2018 Sep;101:1-11
pubmed: 30014970
Eur J Oncol Nurs. 2018 Oct;36:9-15
pubmed: 30322516
Support Care Cancer. 2014 Nov;22(11):3101-20
pubmed: 25120008
J Clin Oncol. 2016 Jan 1;34(1):6-13
pubmed: 26578608
Public Health. 2011 Mar;125(3):145-7
pubmed: 21316066
J Clin Epidemiol. 2014 Dec;67(12):1291-4
pubmed: 25034198
Int J Evid Based Healthc. 2015 Sep;13(3):141-6
pubmed: 26134548
J Clin Oncol. 2018 Apr 10;36(11):1103-1111
pubmed: 29494259
Asia Pac J Oncol Nurs. 2016 Oct-Dec;3(4):316-323
pubmed: 28083548
CA Cancer J Clin. 2004 Mar-Apr;54(2):78-93
pubmed: 15061598
J Intellect Disabil Res. 2017 Jan;61(1):62-74
pubmed: 27489075
BMJ Open. 2018 Feb 25;8(2):e020268
pubmed: 29478966
Cancer. 2008 Jan 15;112(2):228-42
pubmed: 18008363
Curr Oncol. 2019 Feb;26(1):e8-e16
pubmed: 30853804
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
J Appl Res Intellect Disabil. 2015 Sep;28(5):423-35
pubmed: 26256277
J Appl Res Intellect Disabil. 2015 Nov;28(6):455-523
pubmed: 25826389
Implement Sci. 2010 Sep 20;5:69
pubmed: 20854677
Can J Public Health. 2018 Dec;109(5-6):866-872
pubmed: 30151673
Cancer Causes Control. 2011 Mar;22(3):359-66
pubmed: 21221758
Ment Retard Dev Disabil Res Rev. 2006;12(1):70-82
pubmed: 16435327
Cancer Causes Control. 2009 Aug;20(6):989-1000
pubmed: 19199061
CA Cancer J Clin. 2016 Mar-Apr;66(2):134-51
pubmed: 26663383
Curr Oncol. 2016 Aug;23(4):225-32
pubmed: 27536172
Lung Cancer Int. 2016;2016:6787648
pubmed: 27752368
Am J Public Health. 2006 Dec;96(12):2113-21
pubmed: 17077411
Dev Disabil Res Rev. 2013;18(1):6-16
pubmed: 23949824
Cancer Causes Control. 2009 May;20(4):417-35
pubmed: 19002764
BMJ Open. 2014 Feb 14;4(2):e004567
pubmed: 24531454